A new study looks at the patient-burden and quality of life impact of atopic dermatitis. For a breakdown of disease severity correlated to life satisfaction and mental and physical score, read more.

FDA Alerts

FDA Alerts
Thursday, November 30, 2017
The FDA has approved the relabeling of an over-the-counter cream for treatment of eczema.
FDA Alerts
Monday, November 20, 2017
The FDA has expanded the approval of a dermal spray label for the treatment of atopic dermatitis.
FDA Alerts
Tuesday, March 28, 2017
The FDA has approved Regeneron Pharmaceuticals Inc and Sanofi SA's dupilumab (Dupixent) for treatment of moderate to severe atopic dermatitis.
FDA Alerts
Monday, April 25, 2016
The FDA accepted Anacor Pharmaceuticals, Inc’s New Drug Application seeking approval of crisaborole topical ointment, 2%, a novel nonsteroidal topical anti-inflammatory phosphodiesterase-4 (PDE-4) inhibitor in development for the potential treatment of mild to moderate atopic dermatitis.

NEA Approved Content

NEA Approved Content
Monday, July 9, 2018
In part 2, Vivian Shi, MD, discusses which products and ingredients patients should avoid, the Eczema Action Plan, and the top questions she receives most from her patients. Part 1 covered the nonpharmacologic treatment options she discusses with her patients, such as acupuncture, and how she approaches integrative medicine.
NEA Approved Content
Monday, July 2, 2018
The Dermatologist spoke with Vivian Shi, MD, about the use of nonpharmacologic treatment options, such as probiotics, natural oils, and acupuncture for atopic dermatitis (AD), as well as patients’ top questions about skin care. In part 1, Dr Shi discusses which nonpharmacological options she discusses with patients, including acupuncture, and how she approaches integrative medicine.
NEA Approved Content
Wednesday, May 16, 2018
A 34-year-old Filipino woman presented with a lifelong history of extensive atopic dermatitis (AD). Antecubital fossae involvement with lichenification and dyspigmentation is evident.
NEA Approved Content
Monday, March 26, 2018
The scientific talks and posters at the 2018 American Academy of Dermatology (AAD) Annual Meeting presented up-to-date data on therapies for atopic dermatitis. Here are some highlights.

News

News
Tuesday, July 17, 2018
A new study looks at the patient-burden and quality of life impact of atopic dermatitis. For a breakdown of disease severity correlated to life satisfaction and mental and physical score, read more.
News
Tuesday, July 10, 2018
In a recent study, researchers investigated disease control and its effects on health-related quality of life among patients with AD.
News
Thursday, May 31, 2018
In a recent study, Dr Silverberg and colleagues examined the prevalence and costs of emergency department use among patients with AD compared with the general population.​​​​​​​
News
Wednesday, April 25, 2018
This week, the World Allergy Organization will host World Allergy Week, which is dedicated to raising awareness about atopic dermatitis and its role in the atopic march. Learn More.

Polls

Polls
Tuesday, March 27, 2018
To submit your answer, click here
Polls
Monday, March 19, 2018
To submit your answer, click here
Polls
Wednesday, March 7, 2018
To submit your answer, click here

Quizzes

Quizzes
Sunday, March 25, 2018
In which year did Jon M. Hanifin, MD, and Georg Rajka, MD, publish their criteria for diagnosing atopic dermatitis?
Quizzes
Sunday, March 11, 2018
Which type of eczema is characterized by coin-shaped lesions?

Research in Review

Research in Review
Monday, May 21, 2018
A review of recent news, research, and treatment related to eczema.
Research in Review
Tuesday, February 20, 2018
A review of recent news, research, and treatment related to eczema.
Research in Review
Wednesday, December 27, 2017
A review of recent news, research, and treatment related to eczema.
Research in Review
Thursday, December 7, 2017
Peter Moffat talks about his experience with eczema and making awareness and education accessible.